Stocks: Insiders Buy at 4 Biotechs -- Dicerna, Ultragenyx, Regulus, and Cara

By Jonathan Moreland  FEB 06, 2014 10:45 AM

Regulus Therapeutics renewed its strategic alliance with French pharmaceutical company Sanofi, which added $10 million in equity to its stake in the firm.

 


No positions in stocks mentioned.